| |
| Issue |
Title |
| |
| Vol 14, No 3 (2024) |
Preclinical Studies in the Pharmaceutical Development Cycle |
Abstract
PDF (Rus)
|
|
M. N. Makarova |
| |
| Vol 14, No 2 (2024) |
Current Trends in the Study of Promising Medicinal Plant Species |
Abstract
PDF (Rus)
|
|
N. I. Sidelnikov |
| |
| Vol 13, No 4 (2023) |
Russian regulatory system for clinical trials is consistent with international approaches |
Abstract
PDF (Rus)
|
|
Yu. N. Linkova |
| |
| Vol 13, No 3 (2023) |
Quality Assurance of Medicines: Main Scientific Approaches and Control Methods |
Abstract
PDF (Rus)
|
|
E. L. Kovaleva, Yu. A. Zolotov, D. V. Somov |
| |
| Vol 13, No 2 (2023) |
Quality of Herbal Medicines: New Aspects and Solutions |
Abstract
PDF (Rus)
|
|
V. G. Luzhanin, V. A. Kurkin, I. V. Gravel |
| |
| Vol 13, No 1 (2023) |
Pharmaceutical Toxicology is the Most Important Component of Preclinical Studies |
Abstract
PDF (Rus)
|
|
A. D. Durnev |
| |
| Vol 12, No 4 (2022) |
“We should strive to attain Russia’s former standing in nuclear medicine” |
Abstract
PDF (Rus)
|
|
S. N. Kalmykov |
| |
| Vol 12, No 4 (2022) |
“There is a great future for radiopharmaceuticals in Russian medical practice” |
Abstract
PDF (Rus)
|
|
A. D. Kaprin |
| |
| Vol 12, No 4 (2022) |
“Nowadays, doctors have effective tools to treat patients who would have been considered incurable in the past” |
Abstract
PDF (Rus)
|
|
D. N. Maystrenko |
| |
| 1 - 9 of 9 Items |
|
